# Predictive biomarker for liver cancer associated with survival outcomes, effectiveness of systemic therapy

Source: [Medical Xpress - latest medical and health news stories](https://medicalxpress.com/news/2026-11-biomarker-liver-cancer-survival-outcomes.html) · 2026-11-19 · Medicine
Page: https://themorning.science/story/predictive-biomarker-for-liver-cancer-associated-with-survival-outcomes-effectiv-1172af8d5c0c7d0d
Kind: research · Impact: medium

## In brief

- Liver cancer was the sixth most common cancer and the third leading cause of cancer-related deaths worldwide in 2022.
- Hepatocellular carcinoma (HCC) is the most common histological subtype, accounting for approximately 90% of liver cancers.
- A predictive biomarker for liver cancer has been linked to survival outcomes and the effectiveness of systemic therapy.

## Why it matters

A biomarker that predicts survival and response to systemic therapy could help researchers and clinicians stratify liver cancer patients and evaluate treatments. The source material provided does not include further detail on its validation.

## Coverage

- [Predictive biomarker for liver cancer associated with survival outcomes, effectiveness of systemic therapy](https://medicalxpress.com/news/2026-11-biomarker-liver-cancer-survival-outcomes.html) — Medical Xpress - latest medical and health news stories, 2026-11-19

Tags: liver cancer, biomarkers, hepatocellular carcinoma, systemic therapy, cancer survival

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
